Enanta Pharmaceutica (ENTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Sales | 57,262 | 44,049 | 38,109 | 75,927 | 7,511 |
| Gross Profit | 57,262 | 44,049 | 38,109 | 75,927 | 7,511 |
| Operating Expenses | 34,622 | 27,190 | 23,732 | 21,632 | 20,640 |
| Operating Income | 22,640 | 16,859 | 14,377 | 54,295 | -13,129 |
| Other Income | 1,338 | 1,066 | 960 | 660 | 600 |
| Pre-tax Income | 23,978 | 17,925 | 15,337 | 54,955 | -12,529 |
| Income Tax | 3,690 | 5,370 | 3,644 | 18,447 | -4,103 |
| Net Income Continuous | 20,288 | 12,555 | 11,693 | 36,508 | -8,426 |
| Net Income | $20,288 | $12,555 | $11,693 | $36,508 | $-8,426 |
| EPS Basic Total Ops | 1.05 | 0.65 | 0.61 | 1.91 | -0.44 |
| EPS Basic Continuous Ops | 1.05 | 0.65 | 0.61 | 1.92 | -0.44 |
| EPS Diluted Total Ops | 0.97 | 0.61 | 0.59 | 1.89 | -0.44 |
| EPS Diluted Continuous Ops | 0.97 | 0.61 | 0.59 | 1.90 | -0.44 |
| EBITDA(a) | $22,949 | $17,494 | $15,052 | $54,997 | $-12,419 |